Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 26.48 -2.13%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

Rigel Pharmaceuticals Мультипликаторы 2011-2024 | RIGL

Мультипликаторы по годам Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-10.3 -4.4 -24.4 -20.7 -5.9 -4.9 -6.5 -2.8 -4.7 -2.0 -3.1 -4.8 -7.2

P/S

2.2 2.1 2.9 5.7 6.6 7.8 112.4 9.6 8.4 22.0 38.5 212.9 129.5

EPS

-0.1 -0.3 -0.1 -0.2 -0.4 -0.4 -0.6 -0.7 -0.6 -1.0 -1.0 -1.3 -1.4

EV (Enterprise Value)

372 млн 379 млн 555 млн 660 млн 463 млн 301 млн 484 млн 202 млн 240 млн 192 млн 272 млн 467 млн 617 млн

EBITDA per Share

-0.11 -0.32 -0.07 -0.17 -0.409 -0.449 -0.627 -0.668 -0.569 -1.01 -0.976 -1.29 -1.33

EV/EBITDA

-28.4 -21.4 -5.5 -3.8 -5.9 -2.8 -4.0 -1.9 -3.0 -4.6 -7.1

PEG

-0.31 -0.11 0.76 1.22 -0.64 -0.17 -0.43 0.11 -0.11 1.02 -0.14 -1.65 0.02

P/B

-9.1 -18.7 14.4 18.1 7.3 3.2 5.0 3.6 2.7 1.4 1.3 1.7 2.6

P/CF

-45.1 -3.5 74.3 -11.8 -9.1 -5.8 -6.5 -2.6 -10.2 -2.6 -3.2 -5.4 -8.6

ROE %

87.60 430.18 -58.98 -87.42 -124.30 -64.14 -77.49 -125.79 -56.32 -70.89 -42.75 -34.19 -36.41

ROA %

-21.40 -43.62 -10.71 -26.95 -45.33 -50.67 -65.48 -88.59 -39.06 -58.98 -39.38 -31.88 -33.44

ROCE %

71.54 407.98 -41.14 -85.15 -77.32 -65.26 -79.00 -115.17 -52.83 -65.13 -40.69 -33.37 -35.17

Current Ratio

0.8 0.9 1.2 1.4 2.0 4.9 6.4 3.4 3.8 10.7 21.4 24.8 21.7

DSO

110.7 84.7 38.5 43.8 62.2 33.4 - - 2.6 254.4 293.5 - -

DIO

375.8 1641.8 1390.9 610.1 545.5 1137.0 - - - - - - -

DPO

761.1 2744.6 1264.2 1602.5 1672.7 8127.9 - - - - - - -

Операционный цикл

486.4 1726.5 1429.4 653.9 607.7 1170.4 - - - - - - -

Финансовый цикл

-274.6 -1018.1 165.2 -948.6 -1065.0 -6957.5 - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.71 -0.06 -0.05 -0.33 -0.38 -0.08 - -0.11 -0.08 -0.16 - -0.12 -0.08 0.23 -0.11 -0.08 -0.1 0.13 -0.1 -0.07 -0.12 -0.11 0.02 -0.14 -0.16 -0.17 -0.18 -0.14 -0.16 -0.13 -0.16 -0.24 -0.15 -0.19 -0.14 -0.08 -0.16 -0.21 -0.25 -0.24 -0.29 -0.25 -0.19 -0.27 -0.26 -0.29 -0.3 -0.36 -0.35 -0.32 -0.36 -0.25 -0.37 -0.4

EBITDA per Share

0.83 0.06 -0.04 -0.24 -0.29 -0.07 - -0.1 -0.08 -0.15 - -0.11 -0.08 0.25 - -0.08 -0.1 0.13 - -0.07 -0.13 -0.11 - -0.14 -0.16 -0.17 - -0.14 -0.16 -0.14 - -0.23 -0.14 -0.19 - -0.06 -0.15 -0.2 - -0.22 -0.28 -0.25 - -0.25 -0.25 -0.29 - -0.33 -0.33 -0.32 - -0.23 -0.35 -0.39

ROE %

-37.50 70.84 123.20 193.14 271.24 614.70 59.19 17.01 -121.16 -508.38 -12.03 -68.56 -68.04 -36.97 -24.98 -0.41 -51.09 -132.86 -228.00 -193.10 -167.84 -142.30 -131.79 -160.43 -145.14 -133.92 -126.95 -129.57 -175.24 -197.33 -213.85 -199.41 -109.25 -68.15 -56.32 -59.80 -68.83 -73.40 -70.89 -61.62 -56.73 -47.86 -42.75 -43.46 -40.83 -38.45 -34.19 -36.30 -35.09 -35.62 -36.41 -7.59 -9.09 -8.80

ROA %

-3.35 -17.89 -28.04 -37.99 -49.52 -62.29 -53.29 -64.52 -40.88 -47.73 0.20 -17.23 -18.84 -8.66 -7.70 -1.93 -22.76 -51.97 -83.14 -69.17 -88.48 -98.49 -104.10 -128.14 -118.91 -111.94 -107.27 -105.50 -130.38 -141.11 -150.61 -140.29 -76.72 -47.61 -39.06 -43.88 -52.41 -58.32 -58.98 -51.99 -48.94 -42.54 -39.38 -40.14 -37.81 -35.72 -31.88 -33.69 -32.46 -32.83 -33.44 -6.97 -8.35 -8.08

ROCE %

-61.51 53.26 107.21 178.00 256.76 590.63 59.08 19.24 -113.37 -485.13 -5.66 -46.16 -46.83 -78.79 -29.82 -52.19 -34.05 -22.59 -96.17 -118.35 -118.16 -102.27 -68.45 -86.19 -81.76 -77.21 -53.06 -94.38 -117.96 -123.55 -98.05 -105.47 -71.57 -62.06 -42.67 -59.08 -68.07 -72.62 -53.71 -65.20 -60.29 -51.43 -34.83 -43.67 -41.02 -38.64 -25.51 -33.15 -31.95 -32.47 -25.60 -7.64 -9.13 -8.83

Current Ratio

0.9 0.8 0.8 0.8 0.8 0.8 0.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

49.1 69.9 78.9 72.0 85.2 122.0 - 31.6 23.3 83.7 - 68.5 277.2 89.1 79.0 79.3 91.0 21.3 59.9 44.2 88.7 51.3 9.8 76.5 208.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

73.0 237.9 285.9 607.9 927.7 943.1 - 1298.7 297.9 5045.1 - 4190.2 4873.7 1239.5 - 1067.6 535.7 880.7 - 398.6 397.3 958.5 - 1182.3 2719.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

56.5 250.4 389.2 476.4 489.6 1345.1 - 496.6 203.2 3170.8 - 1460.3 2399.4 1270.9 - 2416.2 1212.4 2313.3 - 1222.2 1218.2 4495.6 - 8451.9 19439.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

122.1 307.8 364.8 679.8 1012.9 1065.0 - 1330.3 321.2 5128.9 - 4258.8 5150.9 1328.6 79.0 1146.9 626.7 902.0 59.9 442.8 485.9 1009.8 9.8 1258.8 2927.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

65.5 57.4 -24.4 203.5 523.3 -280.0 - 833.7 118.0 1958.1 - 2798.5 2751.5 57.7 79.0 -1269.3 -585.7 -1411.3 59.9 -779.4 -732.3 -3485.7 9.8 -7193.1 -16511.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD